LTFS
UTHR icon

Ladenburg Thalmann Financial Services’s United Therapeutics UTHR Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$84K Sell
937
-77
-8% -$6.78K ﹤0.01% 3154
2019
Q3 		$81K Buy
1,014
+342
+51% +$27.5K ﹤0.01% 3095
2019
Q2 		$52K Sell
672
-353
-34% -$33K ﹤0.01% 3439
2019
Q1 		$121K Buy
1,025
+182
+22% +$21.2K ﹤0.01% 2765
2018
Q4 		$91K Buy
843
+748
+787% +$86.7K ﹤0.01% 2815
2018
Q3 		$12K Sell
95
-565
-86% -$69.9K ﹤0.01% 4198
2018
Q2 		$74K Hold
660
– – ﹤0.01% 2980
2018
Q1 		$74K Buy
660
+18
+3% +$2.29K ﹤0.01% 2980
2017
Q4 		$96K Buy
642
+59
+10% +$7.5K ﹤0.01% 2760
2017
Q3 		$68K Sell
583
-42
-7% -$5.36K ﹤0.01% 2872
2017
Q2 		$81K Sell
625
-79
-11% -$9.86K ﹤0.01% 2652
2017
Q1 		$96K Sell
704
-13
-2% -$1.97K ﹤0.01% 2430
2016
Q4 		$104K Buy
717
+73
+11% +$9.32K ﹤0.01% 2296
2016
Q3 		$77K Sell
644
-114
-15% -$13.7K ﹤0.01% 2438
2016
Q2 		$81K Sell
758
-184
-20% -$20.5K ﹤0.01% 2307
2016
Q1 		$105K Sell
942
-264
-22% -$33.4K ﹤0.01% 2024
2015
Q4 		$188K Buy
1,206
+73
+6% +$10.6K ﹤0.01% 1626
2015
Q3 		$148K Sell
1,133
-132
-10% -$21.2K ﹤0.01% 1712
2015
Q2 		$219K Buy
1,265
+25
+2% +$4.5K ﹤0.01% 1552
2015
Q1 		$215K Buy
1,240
+395
+47% +$60.2K ﹤0.01% 1524
2014
Q4 		$112K Sell
845
-206
-20% -$26.5K ﹤0.01% 1820
2014
Q3 		$135K Sell
1,051
-209
-17% -$21.5K ﹤0.01% 1437
2014
Q2 		$111K Sell
1,260
-516
-29% -$49.6K ﹤0.01% 1540
2014
Q1 		$167K Buy
1,776
+29
+2% +$2.97K ﹤0.01% 1218
2013
Q4 		$197K Sell
1,747
-136
-7% -$12.3K 0.01% 1085
2013
Q3 		$153K Buy
1,883
+930
+98% +$68K 0.01% 1145
2013
Q2 		$63K Buy
+953
New +$61.4K ﹤0.01% 1571

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Ladenburg Thalmann Financial Services's UTHR Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its United Therapeutics (UTHR) stake by 7.6% in Q4 2019, selling an estimated $6.78K and leaving 937 shares worth $84K. The position accounts for ﹤0.01% of the portfolio, ranked #3154.

Ladenburg Thalmann Financial Services first reported a position in UTHR in Q2 2013 and has held it in 27 quarters since. The position peaked at $219K in Q2 2015. 320 funds tracked by Wall St. Rank hold UTHR as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 937 shares of United Therapeutics worth $84K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 77 United Therapeutics shares in Q4 2019, an estimated $6.78K.
  • United Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3154 holding.
  • Ladenburg Thalmann Financial Services first reported a position in United Therapeutics in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's United Therapeutics position peaked at $219K in Q2 2015.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.